• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于血液学和肿瘤学疾病患儿中Broviac/Hickman导管相关并发症的发生率及转归的前瞻性调查。

A prospective survey on incidence and outcome of Broviac/Hickman catheter-related complications in pediatric patients affected by hematological and oncological diseases.

作者信息

Cesaro Simone, Corrò Roberta, Pelosin Anna, Gamba Piergiorgio, Zadra Nicola, Fusaro Fabio, Pillon Marta, Cusinato Riccardo, Zampieri Chiara, Magagna Laura, Cavaliere Mara, Tridello Gloria, Zanon Gianfranco, Zanesco Luigi

机构信息

Department of Pediatrics, Clinic of Pediatric Hematology Oncology, University of Padova, Via Giustiniani 3, 35128, Padova, Italy.

出版信息

Ann Hematol. 2004 Mar;83(3):183-8. doi: 10.1007/s00277-003-0796-9. Epub 2003 Nov 13.

DOI:10.1007/s00277-003-0796-9
PMID:15064868
Abstract

A prospective pediatric survey on the incidence of central venous catheter (CVC) complications was performed aimed at identifying risk factors of premature CVC removal. The study comprised 129 Broviac-Hickman CVCs inserted during a 13-month period in 112 children. The total number of CVC days was 19,328 (median: 122 days, range: 1-385). The overall rate of complications was 6.2/1000 CVC days, i.e., 4.5/1000 and 1.7/1000 CVC days for mechanical and infectious complications, respectively. Interestingly, only two CVC-related cases of septicemia and no thrombotic events were documented. At the end of the study period, 38 of 129 CVC (29.5%) had been removed: 20 due to CVC-related complications (dislocation18, rupture 2), 10 due to the patient's death, and 8 due to completion of therapy. Age at CVC insertion <4.9 years was a significant predictor of premature CVC removal ( p=0.01). Mechanical complications, especially in younger children, are the main cause of premature loss of CVC. These data underline the importance of more effectively securing the CVC to subcutaneous tissue in pediatric patients to reduce accidental dislocations.

摘要

一项关于中心静脉导管(CVC)并发症发生率的前瞻性儿科调查旨在确定过早拔除CVC的危险因素。该研究纳入了112名儿童在13个月期间插入的129根Broviac-Hickman CVC。CVC留置总天数为19328天(中位数:122天,范围:1 - 385天)。并发症总发生率为6.2/1000 CVC留置日,即机械性并发症和感染性并发症的发生率分别为4.5/1000和1.7/1000 CVC留置日。有趣的是,仅记录到2例与CVC相关的败血症病例,未记录到血栓形成事件。在研究期结束时,129根CVC中有38根(29.5%)已拔除:20根因CVC相关并发症(移位18根,破裂2根),10根因患者死亡,8根因治疗结束。CVC插入时年龄<4.9岁是过早拔除CVC的显著预测因素(p = 0.01)。机械性并发症,尤其是在年幼儿童中,是CVC过早丢失的主要原因。这些数据强调了在儿科患者中更有效地将CVC固定至皮下组织以减少意外移位的重要性。

相似文献

1
A prospective survey on incidence and outcome of Broviac/Hickman catheter-related complications in pediatric patients affected by hematological and oncological diseases.一项关于血液学和肿瘤学疾病患儿中Broviac/Hickman导管相关并发症的发生率及转归的前瞻性调查。
Ann Hematol. 2004 Mar;83(3):183-8. doi: 10.1007/s00277-003-0796-9. Epub 2003 Nov 13.
2
Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer.癌症患儿中心静脉导管两种不同冲洗方式的前瞻性随机试验。
J Clin Oncol. 2009 Apr 20;27(12):2059-65. doi: 10.1200/JCO.2008.19.4860. Epub 2009 Mar 9.
3
Complications of Hickman-Broviac catheters in children with malignancies.希克曼-布罗维阿克导管在恶性肿瘤患儿中的并发症。
Pediatr Hematol Oncol. 2008 Jun;25(5):375-84. doi: 10.1080/08880010802106622.
4
Central venous catheter-related complications after bone marrow transplantation in children with hematological malignancies.血液系统恶性肿瘤患儿骨髓移植后中心静脉导管相关并发症
Bone Marrow Transplant. 1992 Feb;9(2):113-7.
5
Risk factors for central venous catheter thrombotic complications in children and adolescents with cancer.儿童和青少年癌症患者中心静脉导管血栓并发症的危险因素。
Cancer. 2010 Sep 1;116(17):4197-205. doi: 10.1002/cncr.25199.
6
Groshong catheter-related complications in children with cancer.儿童癌症患者的 Groshong 导管相关并发症。
Pediatr Blood Cancer. 2010 Jul 1;54(7):947-51. doi: 10.1002/pbc.22416.
7
Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: a prospective multicentre study.血液系统恶性肿瘤患者中心静脉置管血栓形成并发症的发生率:一项前瞻性多中心研究。
Br J Haematol. 2005 Jun;129(6):811-7. doi: 10.1111/j.1365-2141.2005.05529.x.
8
Results of a long-term, prospective study on complications of central venous catheter in pediatric patients with hematologic-oncologic diseases.一项针对血液肿瘤疾病患儿中心静脉导管并发症的长期前瞻性研究结果。
Pediatr Blood Cancer. 2024 Jul;71(7):e30990. doi: 10.1002/pbc.30990. Epub 2024 Apr 11.
9
A comprehensive approach to the prevention of central venous catheter complications: results of 10-year prospective surveillance in pediatric hematology-oncology patients.预防中心静脉导管并发症的综合方法:儿科血液肿瘤患者10年前瞻性监测结果
Ann Hematol. 2016 Apr;95(5):817-25. doi: 10.1007/s00277-016-2634-x. Epub 2016 Mar 10.
10
Infectious complications of implantable ports and Hickman catheters in paediatric haematology-oncology patients.儿科血液肿瘤患者中植入式端口和希克曼导管的感染并发症
J Hosp Infect. 2006 Mar;62(3):358-65. doi: 10.1016/j.jhin.2005.08.019. Epub 2006 Jan 10.

引用本文的文献

1
Catheter-associated Bloodstream Infection in Children with Tunneled Central Venous Catheters: A Single-center Experience.带隧道式中心静脉导管儿童的导管相关血流感染:单中心经验
J Indian Assoc Pediatr Surg. 2024 Jul-Aug;29(4):329-333. doi: 10.4103/jiaps.jiaps_248_23. Epub 2024 Jul 6.
2
Incidence and risk factors of complications during central venous access devices removal in children.儿童中心静脉通路装置拔除期间并发症的发生率及危险因素
J Vasc Access. 2025 Jul;26(4):1217-1223. doi: 10.1177/11297298241260899. Epub 2024 Aug 3.
3
Factors affecting mechanical complications of central venous access devices in children.
影响儿童中心静脉置管机械并发症的因素。
Pediatr Surg Int. 2022 Jul;38(7):1067-1073. doi: 10.1007/s00383-022-05130-1. Epub 2022 May 5.
4
International Society of Paediatric Surgical Oncology (IPSO) Surgical Practice Guidelines.国际小儿外科肿瘤学会(IPSO)手术实践指南
Ecancermedicalscience. 2022 Feb 17;16:1356. doi: 10.3332/ecancer.2022.1356. eCollection 2022.
5
Vascular access for lipid apheresis: a challenge in young children with homozygous familial hypercholesterolemia.血管通路在儿童纯合子家族性高胆固醇血症患者行血脂吸附治疗中的应用。
BMC Pediatr. 2022 Mar 12;22(1):131. doi: 10.1186/s12887-022-03192-7.
6
Vascular Access in Pediatric Oncology and Hematology: State of the Art.儿科肿瘤学和血液学中的血管通路:最新进展
Children (Basel). 2022 Jan 5;9(1):70. doi: 10.3390/children9010070.
7
Efficacy of ethanol locks to reduce the incidence of catheter-related bloodstream infections for home parenteral nutrition pediatric patients: comparison of therapeutic treatment with prophylactic treatment.乙醇封管降低家庭肠外营养儿科患者导管相关血流感染发生率的疗效:治疗性治疗与预防性治疗的比较
Pediatr Surg Int. 2016 Sep;32(9):863-7. doi: 10.1007/s00383-016-3933-y. Epub 2016 Jul 26.
8
Central venous Access device SeCurement And Dressing Effectiveness (CASCADE) in paediatrics: protocol for pilot randomised controlled trials.儿科中心静脉通路装置固定与敷料有效性(CASCADE):随机对照试验的试验方案
BMJ Open. 2016 Jun 3;6(6):e011197. doi: 10.1136/bmjopen-2016-011197.
9
Diagnostic accuracy of the Catheter Injection and Aspiration (CINAS) classification for assessing the function of totally implantable venous access devices.导管注射与抽吸(CINAS)分类法评估完全植入式静脉通路装置功能的诊断准确性
Support Care Cancer. 2016 Feb;24(2):755-761. doi: 10.1007/s00520-015-2839-x. Epub 2015 Jul 26.
10
Central venous line complications with chronic ambulatory infusion of prostacyclin analogues in pediatric patients with pulmonary arterial hypertension.在患有肺动脉高压的儿科患者中,长期门诊输注前列环素类似物的中心静脉导管并发症
Pulm Circ. 2015 Jun;5(2):322-326. doi: 10.1086/680215.